Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

Gala Health vs Eden

Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.

Grade B · #15

Gala Health

One of the few names on the board that pairs a genuinely cheap compounded entry with a real brand-Ozempic path and nationwide coverage — the verdict docks it only for a sky-high brand sticker and an oral route it doesn't yet offer.

Visit Gala Health
vs
WinnerGrade A− · #2

Eden

A polished, high-disclosure compounded program with strong nationwide coverage.

Visit Eden

The verdict

Winner: Eden

Eden takes it with a higher Verdict Score — 91/100 to 86/100 (grade A− vs B). People who prioritize a vetted, high-transparency provider over the lowest sticker price. Gala Health still earns its place — patients in any state who want to start on low-cost compounded tirzepatide but keep a legitimate brand-name option on the table.

Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

85Real-world results90
87Price honesty89
88Prescriber access95
88Formulary choice86
84Cancellation fairness90
84Member support92

Price, coverage & features

MetricGala HealthEden
Verdict Score86/10091/100
GradeBA−
SemaglutideNot disclosed$239/mo
Tirzepatide$179/mo$349/mo
CoverageAll 50 statesAll 50 states
Brand-name accessYesCompounded only
Oral / sublingualNoNo

Gala Health

What we like

  • Low compounded entry — tirzepatide at $179/mo, microdose at $149/mo, and a 3-month plan from $199/mo
  • Available in all 50 states, so access never blocks the sign-up
  • Offers a real FDA-approved brand path (Ozempic) alongside the compounded track — rare on this list
  • Adjacent HRT and menopause care for patients who want more than a GLP-1 alone

The caveats

  • GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
  • Brand Ozempic runs $1,299/mo — the brand path exists but is priced out of reach for most
  • No oral or sublingual option yet
  • Newer operator (AI Coaching Inc) with a thin public track record — vet the pharmacy yourself

Eden

What we like

  • High verification confidence — clear supply-chain and clinician disclosure
  • Nationwide availability
  • Both molecules offered

The caveats

  • Premium pricing vs the cheapest tiers
  • Compounded only — no brand-name access

Also worth a look

Patients in any state who want to start on low-cost compounded tirzepatide but keep a legitimate brand-name option on the table.

Visit Gala Health Read the full Gala Health review →

Our pick — visit

People who prioritize a vetted, high-transparency provider over the lowest sticker price.

Visit Eden Read the full Eden review →

Keep comparing

Or browse the full comparison hub and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.